GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Evotec SE (MIL:1EVT) » Definitions » Shiller PE Ratio

Evotec SE (MIL:1EVT) Shiller PE Ratio : 149.28 (As of May. 05, 2025)


View and export this data going back to 2023. Start your Free Trial

What is Evotec SE Shiller PE Ratio?

As of today (2025-05-05), Evotec SE's current share price is €7.464. Evotec SE's E10 for the quarter that ended in Dec. 2024 was €0.05. Evotec SE's Shiller PE Ratio for today is 149.28.

The historical rank and industry rank for Evotec SE's Shiller PE Ratio or its related term are showing as below:

MIL:1EVT' s Shiller PE Ratio Range Over the Past 10 Years
Min: 55.53   Med: 146.49   Max: 592.25
Current: 157.33

During the past years, Evotec SE's highest Shiller PE Ratio was 592.25. The lowest was 55.53. And the median was 146.49.

MIL:1EVT's Shiller PE Ratio is ranked worse than
96.2% of 526 companies
in the Drug Manufacturers industry
Industry Median: 24.365 vs MIL:1EVT: 157.33

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Evotec SE's adjusted earnings per share data for the three months ended in Dec. 2024 was €-0.230. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is €0.05 for the trailing ten years ended in Dec. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Evotec SE Shiller PE Ratio Historical Data

The historical data trend for Evotec SE's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evotec SE Shiller PE Ratio Chart

Evotec SE Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 167.00 90.59 139.83 169.24

Evotec SE Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 139.83 99.59 98.33 88.22 169.24

Competitive Comparison of Evotec SE's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Evotec SE's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Evotec SE's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Evotec SE's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Evotec SE's Shiller PE Ratio falls into.


;
;

Evotec SE Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Evotec SE's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=7.464/0.05
=149.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evotec SE's E10 for the quarter that ended in Dec. 2024 is calculated as:

For example, Evotec SE's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-0.23/127.0412*127.0412
=-0.230

Current CPI (Dec. 2024) = 127.0412.

Evotec SE Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201503 -0.010 99.717 -0.013
201506 0.110 100.417 0.139
201509 -0.020 100.417 -0.025
201512 0.040 99.717 0.051
201603 -0.010 100.017 -0.013
201606 0.030 100.717 0.038
201609 0.070 101.017 0.088
201612 0.110 101.217 0.138
201703 0.050 101.417 0.063
201706 0.020 102.117 0.025
201709 0.020 102.717 0.025
201712 0.070 102.617 0.087
201803 0.020 102.917 0.025
201806 0.100 104.017 0.122
201809 0.230 104.718 0.279
201812 0.210 104.217 0.256
201903 0.090 104.217 0.110
201906 -0.020 105.718 -0.024
201909 0.130 106.018 0.156
201912 0.050 105.818 0.060
202003 0.110 105.718 0.132
202006 -0.070 106.618 -0.083
202009 -0.010 105.818 -0.012
202012 0.000 105.518 0.000
202103 0.320 107.518 0.378
202106 0.370 108.486 0.433
202109 0.820 109.435 0.952
202112 -0.200 110.384 -0.230
202203 -0.410 113.968 -0.457
202206 -0.160 115.760 -0.176
202209 -0.270 118.818 -0.289
202212 -0.150 119.345 -0.160
202303 -0.080 122.402 -0.083
202306 -0.080 123.140 -0.083
202309 -0.220 124.195 -0.225
202312 -0.091 123.773 -0.093
202403 -0.120 125.038 -0.122
202406 -0.540 125.882 -0.545
202409 -0.220 126.198 -0.221
202412 -0.230 127.041 -0.230

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Evotec SE  (MIL:1EVT) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Evotec SE Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Evotec SE's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Evotec SE Business Description

Address
Essener Bogen 7, Manfred Eigen Campus, Hamburg, DEU, 22419
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Evotec SE Headlines

No Headlines